| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.4 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |